Current best practices and rationalistic perspectives in causation-based prevention, early detection and multidisciplinary treatment of breast and gastric cancer

Gastric & Breast Cancer e-journal
DOI: 10.2122/gbc.2011.0197


Translational advances and challenges for pharmacogenomics-based prescription of drugs.

Sam Murray, PhD.

Substantial adverse effects, even patient's death, and resistance to currently widely used drugs in the treatment of cancer, cardiovascular and other major disease still remains a big problem in public health including costs. Pharmacogenomics, a rapidly growing part of genomics, provides promises genome sequencing-based identification of genetic variants that may predict sensitivity and adverse events of drugs in individual patients. Here, I describe the latest advances, the limitations in routine clinical practice and the challenges to overcome to reach the optimal prescription of drugs depending on individuality due to pharmacogenomics.

(Citation: Gastric & Breast Cancer 2011; 10(4) 256-261)

This article is 7 pages long.

You can have an online full-text access and a PDF of this article:
  • Either purchase this paper for €33 EUR. Please, click here
Please specify DOI of article
  • Or through one year subscription PayPal

Online ISSN : 1109 - 7647
   Print ISSN : 1109 - 7655

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Search only trustworthy HONcode health websites: